Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Paramount Will Pay $1.5B To Keep Us Rights To Champions League

-Reuters

byBenzinga Newsdesk

August 19, 2022

1 minute read

-Reuters

BeiGene Touts Initial Brukinsa Efficacy, Safety Profile For Leukemia, Compared To Imbruvica

By Vandana Singh

Today, 8:40 AM

BeiGene Ltd (NASDAQ:BGNE) revealed an interim analysis of the Phase 3 ALPINE trial evaluating Brukinsa (zanubrutinib) to Johnson & Johnson’s (NYSE:JNJ) Imbruvica (ibrutinib)…

BGNE

Hexo Q3 2022 Net Loss Grows Staggering 638% To CA$152.7M, Are There Profits?

By Vuk Zdinjak

Today, 8:40 AM

HEXO Corp (NASDAQ: HEXO) (TSX:HEXO) revenue grew 101% in Q3 2022 to CA$45.57 million ($35.26 million) compared to CA$22.66 in Q3 2021.

HEXO

Morgan Stanley Downgrades Fastenal to Underweight, Lowers Price Target to $48

By Benzinga Newsdesk

Today, 8:40 AM

Morgan Stanley analyst Joshua Pokrzywinski downgrades Fastenal (NASDAQ:FAST) from Equal-Weight to Underweight and lowers the price target from $53 to $48.

FAST

DA Davidson Maintains Buy on Hasbro, Raises Price Target to $113

By Benzinga Newsdesk

Today, 8:40 AM

DA Davidson analyst Linda Bolton Weiser maintains Hasbro (NASDAQ:HAS) with a Buy and raises the price target from $112 to $113.

HAS

Paramount Will Pay $1.5B To Keep Us Rights To Champions League

Related Posts

BeiGene Touts Initial Brukinsa Efficacy, Safety Profile For Leukemia, Compared To Imbruvica

Hexo Q3 2022 Net Loss Grows Staggering 638% To CA$152.7M, Are There Profits?

Morgan Stanley Downgrades Fastenal to Underweight, Lowers Price Target to $48

DA Davidson Maintains Buy on Hasbro, Raises Price Target to $113